Nissan Medical Industries Croissance future
Future contrôle des critères 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Nissan Medical Industries.
Informations clés
n/a
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
Medical Equipment croissance des bénéfices | 23.0% |
Taux de croissance des recettes | n/a |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | None |
Dernière mise à jour | n/a |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
We Think Nissan Medical Industries (TLV:NISA) Can Stay On Top Of Its Debt
Aug 29We Think Nissan Medical Industries' (TLV:NISA) Profit Is Only A Baseline For What They Can Achieve
Mar 27Nissan Medical Industries (TLV:NISA) Has A Somewhat Strained Balance Sheet
Mar 18Nissan Medical Industries (TLV:NISA) Will Be Hoping To Turn Its Returns On Capital Around
Nov 30Calculating The Intrinsic Value Of Nissan Medical Industries Ltd (TLV:NISA)
Oct 26Calculating The Intrinsic Value Of Nissan Medical Industries Ltd (TLV:NISA)
Dec 14Is Nissan Medical Industries (TLV:NISA) Using Too Much Debt?
Nov 09Is Nissan Medical Industries (TLV:NISA) Using Too Much Debt?
Jan 03Do Nissan Medical Industries's (TLV:NISA) Earnings Warrant Your Attention?
May 07Under The Bonnet, Nissan Medical Industries' (TLV:NISA) Returns Look Impressive
Apr 14Does Nissan Medical Industries (TLV:NISA) Have A Healthy Balance Sheet?
Mar 27Nissan Medical Industries (TLV:NISA) Shareholders Have Enjoyed An Impressive 227% Share Price Gain
Mar 09Is Nissan Medical Industries Ltd.'s (TLV:NISA) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 18Does Nissan Medical Industries (TLV:NISA) Deserve A Spot On Your Watchlist?
Feb 01Should We Be Excited About The Trends Of Returns At Nissan Medical Industries (TLV:NISA)?
Jan 13Is Nissan Medical Industries (TLV:NISA) Using Too Much Debt?
Dec 26What Can We Conclude About Nissan Medical Industries' (TLV:NISA) CEO Pay?
Dec 11Introducing Nissan Medical Industries (TLV:NISA), A Stock That Climbed 89% In The Last Year
Nov 25Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme Nissan Medical Industries n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.
Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
6/30/2024 | 729 | 19 | 54 | 61 | N/A |
3/31/2024 | 741 | 18 | 87 | 96 | N/A |
12/31/2023 | 734 | 6 | 96 | 106 | N/A |
9/30/2023 | 722 | -9 | 66 | 73 | N/A |
6/30/2023 | 712 | -35 | 81 | 91 | N/A |
3/31/2023 | 698 | -38 | 48 | 58 | N/A |
12/31/2022 | 685 | -36 | 2 | 12 | N/A |
9/30/2022 | 677 | -24 | -7 | 3 | N/A |
6/30/2022 | 658 | 0 | -43 | -35 | N/A |
3/31/2022 | 673 | 16 | -31 | -23 | N/A |
12/31/2021 | 668 | 36 | 10 | 18 | N/A |
9/30/2021 | 675 | 49 | 50 | 60 | N/A |
6/30/2021 | 708 | 66 | 88 | 100 | N/A |
3/31/2021 | 716 | 67 | 119 | 134 | N/A |
12/31/2020 | 721 | 57 | 109 | 123 | N/A |
9/30/2020 | 694 | 42 | 84 | 96 | N/A |
6/30/2020 | 667 | 30 | 78 | 89 | N/A |
3/31/2020 | 636 | 13 | 77 | 87 | N/A |
12/31/2019 | 605 | 16 | 45 | 55 | N/A |
9/30/2019 | 634 | 22 | 54 | 65 | N/A |
6/30/2019 | 634 | 24 | 50 | 62 | N/A |
3/31/2019 | 647 | 32 | 50 | 62 | N/A |
12/31/2018 | 658 | 25 | 74 | 86 | N/A |
9/30/2018 | 631 | 27 | 59 | 70 | N/A |
6/30/2018 | 627 | 24 | 59 | 70 | N/A |
3/31/2018 | 603 | 16 | N/A | 48 | N/A |
12/31/2017 | 584 | 13 | N/A | 52 | N/A |
9/30/2017 | 561 | 5 | N/A | 55 | N/A |
6/30/2017 | 535 | 5 | N/A | 46 | N/A |
3/31/2017 | 520 | 9 | N/A | 46 | N/A |
12/31/2016 | 509 | 18 | N/A | 44 | N/A |
9/30/2016 | 515 | 27 | N/A | 61 | N/A |
6/30/2016 | 515 | 34 | N/A | 74 | N/A |
3/31/2016 | 527 | 37 | N/A | 104 | N/A |
12/31/2015 | 530 | 37 | N/A | 120 | N/A |
9/30/2015 | 530 | 20 | N/A | 131 | N/A |
6/30/2015 | 540 | 6 | N/A | 127 | N/A |
3/31/2015 | 512 | 3 | N/A | 107 | N/A |
12/31/2014 | 512 | 1 | N/A | 77 | N/A |
9/30/2014 | 492 | 11 | N/A | 62 | N/A |
6/30/2014 | 480 | 20 | N/A | 62 | N/A |
3/31/2014 | 490 | 49 | N/A | 67 | N/A |
12/31/2013 | 467 | 47 | N/A | 73 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if NISA's forecast earnings growth is above the savings rate (2.3%).
Bénéfices vs marché: Insufficient data to determine if NISA's earnings are forecast to grow faster than the IL market
Croissance élevée des bénéfices: Insufficient data to determine if NISA's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: Insufficient data to determine if NISA's revenue is forecast to grow faster than the IL market.
Croissance élevée des revenus: Insufficient data to determine if NISA's revenue is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if NISA's Return on Equity is forecast to be high in 3 years time